MicroRNA Profiling in the Aqueous Humor of Keratoconus Eyes.


Journal

Translational vision science & technology
ISSN: 2164-2591
Titre abrégé: Transl Vis Sci Technol
Pays: United States
ID NLM: 101595919

Informations de publication

Date de publication:
01 12 2022
Historique:
entrez: 6 12 2022
pubmed: 7 12 2022
medline: 15 12 2022
Statut: ppublish

Résumé

To identify differentially expressed (DE) microRNAs (miRNAs) in the aqueous humor (AH) of keratoconus (KC) eyes using next-generation sequencing and to explore whether DE miRNAs might play roles in KC pathophysiology. The small RNAs in the AH of 15 KC eyes and 15 myopia eyes (the control group) were sequenced on an Illumina NovaSeq 6000 platform. Gene Oncology and Kyoto Encyclopedia of Genes and Genome enrichment analyses were performed. Receiver operating characteristic curves were used to identify potential KC biomarkers. We identified 204 miRNAs in the AH of the KC group and 200 in the AH of the control group. Fourteen miRNAs were differentially expressed between the two groups; four miRNAs were upregulated and 10 downregulated in KC AH. The possible pathways regulated by the DE miRNAs included antigen processing and presentation, endocytosis, mismatch repair, and Hippo signaling. The AH concentrations of miR-222-3p, miR-363-3p, and miR-423-5p exhibited areas under the curves of 1. We profiled the DE miRNAs of the AH of KC eyes. These miRNAs may be associated with KC pathogenesis and could serve as KC biomarkers. Data on aberrantly expressed miRNAs in KC combined with bioinformatics analyses suggest possible roles for specific miRNAs. The DE miRNAs may serve as diagnostic KC biomarkers.

Identifiants

pubmed: 36472881
pii: 2783906
doi: 10.1167/tvst.11.12.5
pmc: PMC9733654
doi:

Substances chimiques

MicroRNAs 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5

Références

J Proteomics. 2013 Jul 11;87:122-31
pubmed: 23727491
Clinics (Sao Paulo). 2022 Mar 24;77:100026
pubmed: 35339759
Biol Proced Online. 2014 Mar 14;16(1):5
pubmed: 24629058
J Refract Surg. 2013 Apr;29(4):230-2
pubmed: 23557219
Cornea. 2008 Dec;27(10):1109-13
pubmed: 19034122
Vestn Oftalmol. 1998 Jul-Aug;114(4):38-40
pubmed: 9771088
Ther Adv Ophthalmol. 2021 Jun 24;13:25158414211012796
pubmed: 34263132
Data Brief. 2019 Oct 22;27:104694
pubmed: 31720341
J Ophthalmol. 2019 Dec 23;2019:2424956
pubmed: 31976085
Eur Rev Med Pharmacol Sci. 2018 Jul;22(14):4427-4430
pubmed: 30058674
Invest Ophthalmol Vis Sci. 2013 Aug 05;54(8):5266-72
pubmed: 23833072
Cont Lens Anterior Eye. 2007 Sep;30(4):223-32
pubmed: 17481941
PLoS One. 2019 Jun 12;14(6):e0218282
pubmed: 31188886
Mol Vis. 2020 Feb 01;26:1-13
pubmed: 32165822
Exp Eye Res. 2020 Jun;195:108034
pubmed: 32333905
Acta Ophthalmol. 2012 Sep;90(6):e482-6
pubmed: 22682160
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(8):3731-9
pubmed: 27415791
Nature. 2010 Aug 12;466(7308):835-40
pubmed: 20703300
Cornea. 2023 Jan 1;42(1):60-65
pubmed: 35184126
J Refract Surg. 2017 Feb 1;33(2):84-88
pubmed: 28192586
Transl Vis Sci Technol. 2020 May 19;9(6):16
pubmed: 32821513
Invest Ophthalmol Vis Sci. 2016 Oct 01;57(13):5372-5382
pubmed: 27732724
Biomed Res Int. 2015;2015:604508
pubmed: 26380287
Mol Med. 2020 Dec 4;26(1):122
pubmed: 33276722
Eye (Lond). 2014 Feb;28(2):189-95
pubmed: 24357835
Ophthalmic Genet. 2015;36(3):244-7
pubmed: 24138095
Eur J Ophthalmol. 2021 Nov;31(6):3518-3524
pubmed: 34213382
BMC Ophthalmol. 2021 Oct 25;21(1):377
pubmed: 34696757
Mol Cell Endocrinol. 2017 Sep 5;452:33-43
pubmed: 28487236
Exp Eye Res. 2001 Aug;73(2):179-89
pubmed: 11446768
Clin Exp Ophthalmol. 2020 Jul;48(5):624-635
pubmed: 32173975
Oncogene. 2012 Apr 5;31(14):1743-56
pubmed: 21874053
Middle East Afr J Ophthalmol. 2013 Jul-Sep;20(3):212-6
pubmed: 24014983
J Cell Mol Med. 2019 Jun;23(6):3824-3832
pubmed: 30945448
Exp Eye Res. 2013 Mar;108:68-71
pubmed: 23146683
Invest Ophthalmol Vis Sci. 2010 Jul;51(7):3424-32
pubmed: 20164452
Reprod Sci. 2022 May;29(5):1486-1497
pubmed: 34796469
J Cell Physiol. 2019 Aug;234(10):18849-18857
pubmed: 30927257
Biochim Biophys Acta. 2006 Apr;1762(4):431-9
pubmed: 16516444
Cell. 2018 Aug 9;174(4):1038-1038.e1
pubmed: 30096304
Am J Hum Genet. 2011 Nov 11;89(5):628-33
pubmed: 21996275
Cornea. 2016 Jun;35(6):807-13
pubmed: 27078004
Oncotarget. 2020 May 26;11(21):2010-2023
pubmed: 32523655
Cell Signal. 2013 Dec;25(12):2840-7
pubmed: 24018047
Eur J Hum Genet. 2017 May;25(5):582-590
pubmed: 28145428
Graefes Arch Clin Exp Ophthalmol. 2015 Mar;253(3):335-42
pubmed: 24970617
J Refract Surg. 2018 Mar 1;34(3):201-211
pubmed: 29522231
Mol Vis. 2013;19:430-40
pubmed: 23441115
Epigenetics. 2021 Sep;16(9):1000-1015
pubmed: 33092484
PeerJ. 2020 Aug 20;8:e9793
pubmed: 32879808
Br J Ophthalmol. 2018 Oct;102(10):1436-1441
pubmed: 29298777
J Cell Mol Med. 2020 Nov;24(21):12390-12400
pubmed: 32951332
Transl Vis Sci Technol. 2021 Feb 5;10(2):14
pubmed: 34003899
J Cell Physiol. 2020 Dec;235(12):9323-9335
pubmed: 32346884

Auteurs

Yingjie Zhang (Y)

Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.
Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, China.

Danyang Che (D)

Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.
Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, China.

Yiting Cao (Y)

Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.
Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, China.

Yu Yue (Y)

The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Lab of Ophthalmology, Chongqing Eye Institute, Chongqing Branch of National Clinical Research Center for Ocular Diseases, Chongqing, China.

Tianrui He (T)

Shanghai JiaoTong University School of Medicine, Shanghai, China.

Yi Zhu (Y)

Aier Institute of Optometry and Vision Science, Changsha, China.
Shanghai Aier Eye Hospital, Shanghai, China.

Jibo Zhou (J)

Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.
Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, China.

Articles similaires

Humans Colorectal Neoplasms Biomarkers, Tumor Prognosis Gene Expression Regulation, Neoplastic
Humans RNA, Circular Exosomes Cell Proliferation Epithelial-Mesenchymal Transition

The significance of miR-124 in the diagnosis and prognosis of glioma: A systematic review.

Elham Ghasemi, Mahdieh Mondanizadeh, Amir Almasi-Hashiani et al.
1.00
Humans MicroRNAs Glioma Prognosis Biomarkers, Tumor

Classifications MeSH